Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2020

Apr 15, 2020

34395_dirs_2020-04-15_0f98a659-1b66-4fc3-9eb3-9e115b8bfe6e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-04-13

Reporting Person: Rootsaert Rodney Gerard (Secretary)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-13 Stock Option (Right to Buy) $3.6 A 55000 Acquired 2026-04-13 Common Stock (55000) Direct

Footnotes

F1: A total of 55,000 Options were granted on April 13, 2020 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.